Objectives: Head and neck cancer (HNC) patients often require percutaneous gastrostomy (PEG) tube placement due to malnutrition and dysphagia. While beneficial, PEG tube placement can cause a rare but reportable complication of metastasis of the original tumor to the gastrostomy exit site. The objectives of this case series were to present HNC patients at a single institution that developed PEG tube metastases, their subsequent treatment, and review of the literature for similar cases.
INTRODUCTION
Due to their disease burden and subsequent treatment, many head and neck cancer (HNC) patients face the challenge of malnutrition secondary to tumor or treatment-related dysphagia. 1 Enteral feeding via a percutaneous endoscopic gastrostomy (PEG) tube is frequently required to address this. 2, 3 Its advantages include low cost, the ability to maintain gut function, and improved comfort and convenience over nasoenteral feeding. 4 There are three commonly used methods for PEG tube placement which include: the tube being pulled into the stomach via the Ponsky-Gauderer pull, the tube being pushed over a wire through the mouth via the Sacks-Vine push technique, or the tube being pushed over a dilator via the Russel introducer technique. The pull technique is the most commonly used due to its low complication rate. 1 Complication rates with PEG tube placement have been found to be between 15-35 percent. 1 A rare complication that has been reported in studies of HNC patients is tumor metastasis to the PEG tube site. Due to its rare occurrence, the incidence and risk factors for this complication are not well described. We describe three different patients with HNC who experienced PEG site metastases, including their initial presentation and treatment course
CASE REPORT
We identified three HNC patients who underwent PEG tube placement and were subsequently diagnosed with PEG tube metastasis at a single institution. Demographic data as well as primary tumor characteristics and treatment information are summarized in Table I . PEG tube placement characteristics are summarized in Table II .
Case 1
Patient 1 was 57 years old at the time of presentation. He underwent a PEG tube placement prior to definitive chemoradiotherapy for a T3N2c squamous cell carcinoma of the oropharynx. The PEG tube placement was complicated by development of a rectus sheath abscess on postoperative day 7. This was successfully treated with incision and drainage and antibiotics. At three months after completion of treatment, computed tomography (CT) imaging revealed evidence of lung metastases. At four months after completion of treatment he presented with a painful bleeding mass at the This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
From the Department of Otolaryngology, Thomas Jefferson University, Philadelphia, Pennsylvania.
Editor's Note: This Manuscript was accepted for publication 21 October 2017.
There are no financial interests or conflicts of interests to disclose. 
Case 2
Patient 2 was 60 years old at the time of presentation. He underwent a PEG tube placement prior to definitive chemoradiotherapy for a T3N2c squamous cell carcinoma of the oropharynx. At three months after completion of treatment, surveillance PET/CT imaging revealed evidence of omental mass. Follow-up ultrasound was concerning for drop metastasis separate from the PEG Tube site. Fine needle aspiration (FNA) was negative for malignancy. The PEG tube was removed and he was taken to the OR for definitive excisional biopsy which confirmed squamous cell carcinoma with negative margins. At four months after completion of treatment, he presented with a painful bleeding mass at the PEG tube site. Biopsy confirmed squamous cell carcinoma. He subsequently developed recurrence in the oropharynx and succumbed due complications of its treatment oral cavity. The surgery was noted for lymph nodes with positive extracapsular extension as well as lymphovascular and perineural invasion. She subsequently completed chemoradiation. At four months after completion of treatment, she presented with pain at the PEG tube site. CT imaging revealed hyperdense lesion at PEG tube site. Biopsy confirmed squamous cell carcinoma. Her tube was removed and underwent resection of the mass with negative margins and jejunostomy tube placement which was subsequently removed. Patient is currently disease free.
DISCUSSION
Due to its low occurrence, it has been difficult to quantify the incidence of abdominal wall metastasis in HNC patients. 5 There have been 143 reported cases of head and neck cancers seeding to the PEG tube port site as well as one reported case of metastasis from an open gastrostomy tube site. 6 Of those 144 cases, almost all cases were either stage 3 or stage 4 tumors with tumor subsites either in the oral cavity or the larynx. Previous studies have identified key risk factors for stomal metastasis including: primary advanced stage pharyngeoesophageal tumor and squamous cell histology with poor or moderate differentiation. 7 All of these factors were present in this case series.
There have been multiple theories proposed for the mechanism behind stomal seeding in HNC patients. One theory proposed the insertion of the PEG tube in active HNC causes disruption of the primary tumor, leading to seeding of the PEG tube site. One study found 9 of 40 patients with HNC who underwent PEG tube placement via the pull through method had tumor cells at their stomal site immediately after tube placement. 8 Another theory focuses hematogenous spread from the primary head and neck site to a susceptible site which is supported by patients with PEG tube metastases often have metastases at other locations. 9 For this case series, Patient 1 supports the latter theory, due to the presence of a lung metastasis before the PEG tube metastasis occurred. All three patients also support the disruption theory since both had their PEG tubes placed via the pull method. Overall, the pull method has the greatest association with stomal metastasis compared to the other PEG tube placement techniques.
In reviewing techniques for PEG site metastasis removal, a study reported a successful removal of a PEG tube metastasis via bloc resection including a total gastrectomy with part of the abdominal wall removed with the stomach. 9 This study, along with the above reported cases help show that PEG tube metastasis can be treated surgically that potentially can lead to curative outcomes.
CONCLUSION
While surgical technique may contribute to the risk of stomal metastasis, tumor biology, location, staging, and differentiation seem to be stronger risk factors for the overall prognosis and risk of metastatic disease. For patients with these risk factors, other methods of PEG tube placement, including the push guidewire and direct introducer may lower the risk of metastatic disease. In addition, surgical resection can be potentially curative for these patients. 
